(Q51782295)

12 April 2018

title

Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. (English)

1 reference

12 April 2018

1 reference

Sanziana Roman

1

1 reference

12 April 2018

Rong Lin

series ordinal

2

1 reference

12 April 2018

Julie Ann Sosa

series ordinal

3

1 reference

12 April 2018

language of work or name

English

0 references

publication date

1 November 2006

1 reference

12 April 2018

number of pages

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

12 April 2018

volume

107

1 reference

12 April 2018

issue

9

1 reference

12 April 2018

page(s)

2134-2142

1 reference

12 April 2018

The management of thyroid cancer in adults: a review of new guidelines.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Guidelines for the management of thyroid cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Extent of disease and practice patterns for medullary thyroid cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Medullary thyroid carcinoma: nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Rationale for Central and Bilateral Lymph Node Dissection in Sporadic and Hereditary Medullary Thyroid Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Lymph node involvement in macroscopic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Single center experience in primary surgery for medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

The importance of surgeon experience for clinical and economic outcomes from thyroidectomy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22244

7 January 2021

Identifiers

DOI

10.1002/CNCR.22244

1 reference

12 April 2018

1 reference

12 April 2018